secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2025-12-23T23:59:59+00:00
Accession:  0001213900-25-125299
Event type: m_and_a
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma subsidiary acquires Ipragliflozin patent for $9.8M in stock
------------------------------------------------------------------------

- Hainan Helpson enters Technology Transfer Agreement to acquire Ipragliflozin tablet patent from Juan Zhang.
- Total consideration: $9.8 million paid in 7,000,000 restricted CPHI shares at $1.40 per share.
- Transferor to provide technical services including product R&D, registration materials, and application.
- Shares issued under Regulation S to non-U.S. person, unregistered and exempt from Securities Act registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390025125299/0001213900-25-125299-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390025125299/ea0270909-8k_chinapharm.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-125299

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer